2025-11-15 - Analysis Report
Okay, let's analyze Sempra (SRE) based on the provided data.

## Sempra (SRE) Stock Analysis

Here's a summary analysis broken down by section.

### 1. Performance vs. S&P 500 (VOO)

**Company Overview:** Sempra is an energy infrastructure company serving North America.

**Key Numbers:**

*   **SRE Cumulative Return:** 18.96%
*   **VOO Cumulative Return:** 98.45%
*   **Deviation:**
    *   **Current:** -79.5%
    *   **Range:** Max 13.2%, Min -90.5%
    *   **Relative Deviation:** 10.6% (Indicates SRE is near the bottom of its historical deviation range compared to VOO)

**Analysis:**

Sempra has significantly underperformed the S&P 500 (VOO) over the tracked period. The relative deviation suggests it's currently near its historical low compared to the index. This underperformance warrants further investigation into the specific reasons (industry headwinds, company-specific issues, etc.).

**Alpha, Beta Analysis Table:**

| Year       | CAGR    | MDD   | Alpha   | Beta  | Cap(B) |
| :----------- | :------ | :------ | :------ | :---- | :------ |
| 2015-2017  | 8.0%    | 70.6% | -19.0% | 0.1   | 35.0   |
| 2016-2018  | 11.0%   | 71.1% | -5.0%  | 0.1   | 35.4   |
| 2017-2019  | 35.0%   | 71.1% | 13.0%  | 0.2   | 49.5   |
| 2018-2020  | -4.0%   | 80.1% | -28.0% | 0.2   | 41.7   |
| 2019-2021  | -2.0%   | 80.1% | -49.0% | 0.4   | 43.3   |
| 2020-2022  | -15.0%  | 81.1% | -14.0% | 0.4   | 50.5   |
| 2021-2023  | 22.0%   | 81.1% | 20.0%  | 0.5   | 48.9   |
| 2022-2024  | 11.0%   | 81.1% | -10.0% | 0.6   | 57.4   |
| 2023-2025  | -10.0%  | 74.5% | -73.0% | -0.2  | 60.2   |

**Analysis:**

*   **CAGR:**  The Compound Annual Growth Rate varies significantly across the periods, with negative growth in recent years.
*   **MDD:** Maximum Drawdown is consistently high, indicating substantial risk.
*   **Alpha:**  Alpha is largely negative, suggesting underperformance relative to the benchmark. The recent periods show particularly poor Alpha.
*   **Beta:** Beta is low (mostly below 0.5), indicating lower volatility than the market. The recent period shows negative Beta.
*   **Cap:** Market Cap has been increasing over time.

### 2. Recent Stock Price Movement

*   **Current Price:** $92.0
*   **Previous Close:** $92.22
*   **Change:** -0.24
*   **5-day Moving Average:** 92.632
*   **20-day Moving Average:** 92.5794
*   **60-day Moving Average:** 88.2061

**Analysis:**

The current price is slightly below the 5-day and 20-day moving averages, suggesting a possible short-term downward trend. However, the price is above the 60-day moving average, indicating a longer-term upward trend. The change is minimal.

### 3. Market Risk Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment)
*   **RSI:** 41.98 (Approaching Oversold)
*   **PPO:** -0.3386
*   **Hybrid Signal:** Cash_0%_Buy 100% of cash (23 shares - Very Safe - MRI:0.90) Dividend_0.65 Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-10-01)
*   **20-day Delta Relative Deviation:** +4.3 (Short-term Increase)
*   **Expected Return:** -269.1% (Significant Underperformance)

**Analysis:**

*   The MRI suggests a "Medium Investment" recommendation.
*   The RSI is around 42, indicating neutral momentum, it is heading for oversold.
*   A rising "20-day Delta Relative Deviation" is potentially bullish.
*   The "Hybrid Signal" shows a buy signal, but it is based on a very safe profile (MRI: 0.90), which has been shown to be inaccurate.
*   The very negative "Expected Return" is concerning, implying the model anticipates long-term underperformance compared to the S&P 500.

### 4. Recent News & Significant Events

*   **Mixed Headlines:**  The news is mixed.
    *   Goldman Sachs upgraded Sempra to "Buy," with a price target of $106.
    *   Wolfe adjusted the price target down to $95 but maintained an "Outperform" rating.
    *   There are concerns about insider selling, which is usually a bearish signal.
    *   Spire had a Q4 Loss Wider Than Estimates.
    *   Other articles discuss valuation and upside potential.

**Analysis:**

The analyst opinions are divided, with some positive upgrades and others adjusting price targets. The insider selling is a cause for concern, and you should investigate the context behind this selling activity.

### 4-2) Analyst Opinions

*   **Consensus:** "Buy" (Mean = 1.82)
*   **Target Price:** $99.13 (Average)
*   **Recent Rating Changes:** No specific changes provided.

**Analysis:**

The analyst consensus is generally positive, with a "Buy" rating and an average target price slightly above the current price. However, it's important to consider the range of target prices and the recent adjustments made by individual analysts.

### 5. Recent Earnings Analysis

| Date       | EPS  | Revenue     |
| :---------- | :---- | :---------- |
| 2025-11-05 | 0.12 | $2.76B      |
| 2025-08-07 | 0.71 | $2.70B      |
| 2025-05-08 | 1.39 | $3.68B      |
| 2024-11-06 | 1.01 | $2.57B      |
| 2025-11-05 | 1.01 | $2.57B      |

**Analysis:**

*   EPS has been volatile, with a significant drop in the most recent quarter.
*   Revenue has also fluctuated, with no clear upward trend.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
| :------------ | :-------- | :------------- |
| 2025-09-30   | $3.15B   | 42.94%       |
| 2025-06-30   | $3.00B   | 46.73%       |
| 2025-03-31   | $3.80B   | 47.21%       |
| 2024-12-31   | $3.76B   | 49.23%       |
| 2024-09-30   | $2.78B   | 44.49%       |

**Capital and Profitability:**

| Quarter      | Equity    | ROE    |
| :------------ | :--------- | :----- |
| 2025-09-30   | $31.17B   | 0.30%  |
| 2025-06-30   | $31.72B   | 1.49%  |
| 2025-03-31   | $31.66B   | 2.90%  |
| 2024-12-31   | $31.24B   | 2.16%  |
| 2024-09-30   | $29.72B   | 2.18%  |

**Analysis:**

*   Revenue has been fluctuating, with the most recent quarter showing a decline compared to previous quarters.
*   Profit margins are relatively stable.
*   Equity has been increasing gradually.
*   ROE has decreased significantly in the most recent quarter, indicating a decline in profitability relative to equity.

### 7. 종합 분석 (Comprehensive Analysis)

**Summary:**

The analysis paints a mixed picture for Sempra (SRE).

*   **Underperformance:** Sempra has significantly underperformed the S&P 500 historically, and its expected future performance is also concerning.
*   **Mixed Signals:** Technical indicators and analyst ratings provide conflicting signals. The analyst's ratings is generally positive, but the hybrid signal is inaccurate.
*   **Earnings and Financials:** Recent earnings and financial data show a decline in EPS, revenue, and ROE.
*   **News:** The recent news headlines offer positive and negative elements, with an analyst upgrade countered by insider selling concerns.

**Conclusion:**

Based on this data, I would approach Sempra with caution.
